Several hundred units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the Food and Drug Administration.

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for unresectable or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.

The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.

White and Hispanic US veterans with a diagnosis of ultrashort Barrett esophagus had an increased risk of persistent Barrett esophagus.

In a study of adults with diabetes and gastrointestinal (GI) motility abnormalities, over 75% had GI motility abnormalities.

In a US study, patients with severe eosinophilic esophagitis (EoE) by Index of Severity for EoE had poor responses to topical corticosteroid therapy.

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Key labs at the US CDC have shut down amid recent layoffs, raising concerns about tracking and controlling serious infections.

A senior government health researcher announced his retirement, accusing the NIH of censoring his latest findings on ultra-processed food.

The Trump administration is weighing a plan to cut nearly a third of the federal health budget and eliminate dozens of programs.

A federal team responsible for setting poverty guidelines that determine who qualifies for health and food assistance has been fired.